|
|
Efficacy analysis of different treatment methods for treating type Ⅲ cesarean scar pregnancy |
1. Postgraduate Training Base1 of Hubei Medicine College of Jinzhou Medical University, Shiyan,Hubei Province, 442000;2. The People's Hospital of Shiyan City; 3. Hubei Medicine College |
|
|
Abstract To compare the clinical efficacy of different methods for treating patients with Ⅲ type cesarean scar pregnancy (CSP). Methods: The clinical data of 90 patients with Ⅲ type CSP were collected retrospectively. These patients were all treated by hysteroscopic curettage and were divided into three groups based on different pretreatments. The patients in group A were given uterine artery embolization as pretreatments, the patients in group B were given methotrexate (MTX) fetal sac injection combined with mifepristone as pretreatments, and the patients in group C were given mifepristone combined with misoprostol tablets as pretreatments. Results: Postoperative recovery time of HCG of patients in group A was 12.9±2.1d, which was significant less than that (19.4±3.7d) of patients in group B and that (24.5±2.7d) of patients in group C (F=12.104, P=0.008), and intraoperative blood loss of patients in group A was 81.9±7.0ml, which was also significant less than that (119.2±10.5ml) of patients in group B and that (135.0±13.3 ml) of patients in group C (F=20.068, P=0.002). The time of hospitalization of patients in group B was 15.4±4.2d, which was significant longer than that (7.3±1.9d) of patients in group A and that (8.5± 2.2d) of patients in group C (F=6.586, P=0.031). The hospitalization expenses of patients in group A was 13932.5±1527.3 Yuan, which was significant higher than that (6864.7±981.4 Yuan) of patients in group B and that (5510.8±717.6 Yuan) of patients in group C (F=48.305, P=0.000). Conclusion: Uterine artery embolization combined with hysteroscopic curettage for treating patients with III type CSP has high success rate, which can remove the lesion safely and reliably, but the hospitalization expenses is higher.
|
|
|
|
|
|
|
|